Tubulis
Marcus Gerlach is the Head of Research Bioconjugation & Bioanalytics at Tubulis.
Marcus earned his MS in Biochemistry and Chemistry from Bielefeld University in 2012.
This person is not in any offices
Tubulis
2 followers
Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Their goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. They will advance a range of conjugates, unlimited by indication, using their own discovery capabilities and by solving development challenges for partners with both antibody and chemical assets.